Extracellular vesicles in renal disease

[1]  M. Segelmark,et al.  C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles. , 2017, Journal of the American Society of Nephrology : JASN.

[2]  M. Delhaye,et al.  Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses. , 2017, Gastroenterology.

[3]  G. Camussi,et al.  The effects of glomerular and tubular renal progenitors and derived extracellular vesicles on recovery from acute kidney injury , 2017, Stem Cell Research & Therapy.

[4]  S. Loos,et al.  Haemolytic uraemic syndrome , 2017, Journal of internal medicine.

[5]  Joshua M. Weiss,et al.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.

[6]  A. Zarbock,et al.  Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response , 2016, Nature Communications.

[7]  Weian Zhao,et al.  Stem Cell Extracellular Vesicles: Extended Messages of Regeneration , 2016, Annual review of pharmacology and toxicology.

[8]  L. Lerman,et al.  Comparative proteomic analysis of extracellular vesicles isolated from porcine adipose tissue-derived mesenchymal stem/stromal cells , 2016, Scientific Reports.

[9]  V. Garovic,et al.  Preeclampsia and Extracellular Vesicles , 2016, Current Hypertension Reports.

[10]  D. Gozal,et al.  Extracellular microvesicle microRNAs in children with sickle cell anaemia with divergent clinical phenotypes , 2016, British journal of haematology.

[11]  G. Camussi,et al.  Stem Cell-Derived Extracellular Vesicles and Immune-Modulation , 2016, Front. Cell Dev. Biol..

[12]  James W. Clancy,et al.  Biology and biogenesis of shed microvesicles , 2016, Small GTPases.

[13]  T. Kleffmann,et al.  Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles , 2016, Oncotarget.

[14]  N. Heegaard,et al.  "Kill" the messenger: Targeting of cell-derived microparticles in lupus nephritis. , 2016, Autoimmunity reviews.

[15]  P. Simioni,et al.  Microparticles as biomarkers of venous thromboembolic events. , 2016, Biomarkers in medicine.

[16]  E. Lo,et al.  Transfer of mitochondria from astrocytes to neurons after stroke , 2016, Nature.

[17]  M. Stowell,et al.  Exosomes and other extracellular vesicles in neural cells and neurodegenerative diseases. , 2016, Biochimica et biophysica acta.

[18]  A. Glass,et al.  High intravascular tissue factor—but not extracellular microvesicles—in septic patients is associated with a high SAPS II score , 2016, Journal of Intensive Care.

[19]  L. Lerman,et al.  Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  L. Zitvogel,et al.  Dendritic cell-derived exosomes for cancer therapy. , 2016, The Journal of clinical investigation.

[21]  P. Williamson,et al.  Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane. , 2016, Physiological reviews.

[22]  E. O'Duibhir,et al.  Vasopressin Regulates Extracellular Vesicle Uptake by Kidney Collecting Duct Cells. , 2016, Journal of the American Society of Nephrology : JASN.

[23]  G. Cai,et al.  Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy , 2016, Scientific Reports.

[24]  Joanne Lannigan,et al.  Analytical challenges of extracellular vesicle detection: A comparison of different techniques , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[25]  S. Lim,et al.  MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA , 2016, Journal of extracellular vesicles.

[26]  A. Rule,et al.  Specific renal parenchymal-derived urinary extracellular vesicles identify age-associated structural changes in living donor kidneys , 2016, Journal of extracellular vesicles.

[27]  James W. Clancy,et al.  Tumor‐derived microvesicles in the tumor microenvironment: How vesicle heterogeneity can shape the future of a rapidly expanding field , 2015, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  H. Haller,et al.  Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell-Mediated Rejection of Renal Allografts. , 2015, Clinical chemistry.

[29]  J. Klein,et al.  Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy , 2015, Proteomics.

[30]  A. Ortiz,et al.  Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes. , 2015, Translational research : the journal of laboratory and clinical medicine.

[31]  James W. Clancy,et al.  Extracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion , 2015, Scientific Reports.

[32]  Simon C Watkins,et al.  Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs , 2015, Nature Communications.

[33]  Min Chen,et al.  Promotion of Hypercoagulability in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis by C5a‐Induced Tissue Factor–Expressing Microparticles and Neutrophil Extracellular Traps , 2015, Arthritis & rheumatology.

[34]  S. Sadallah,et al.  Mechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG) , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[35]  S. Nagata,et al.  TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets , 2015, Proceedings of the National Academy of Sciences.

[36]  Emily K. Sims,et al.  Minireview: Emerging Roles for Extracellular Vesicles in Diabetes and Related Metabolic Disorders. , 2015, Molecular endocrinology.

[37]  J. Ordi‐Ros,et al.  miR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  Roman M. Ženka,et al.  Identification of Biomarkers for PKD1 Using Urinary Exosomes. , 2015, Journal of the American Society of Nephrology : JASN.

[39]  C. Lawson,et al.  Long-term high fat feeding of rats results in increased numbers of circulating microvesicles with pro-inflammatory effects on endothelial cells. , 2015, The British journal of nutrition.

[40]  Weihong Zhao,et al.  Influence of erythropoietin on microvesicles derived from mesenchymal stem cells protecting renal function of chronic kidney disease , 2015, Stem Cell Research & Therapy.

[41]  James W. Clancy,et al.  Regulated Delivery of Molecular Cargo to Invasive Tumor-derived Microvesicles , 2015, Nature Communications.

[42]  P. Provero,et al.  AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs. , 2015, Journal of the American Society of Nephrology : JASN.

[43]  T. Du,et al.  Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Facilitate Tubular Epithelial Cell Dedifferentiation and Growth via Hepatocyte Growth Factor Induction , 2015, PloS one.

[44]  Antonella Bongiovanni,et al.  EVpedia: a community web portal for extracellular vesicles research , 2015, Bioinform..

[45]  M. Wauben,et al.  Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[46]  M. Mörgelin,et al.  A Novel Mechanism of Bacterial Toxin Transfer within Host Blood Cell-Derived Microvesicles , 2015, PLoS pathogens.

[47]  C. Rylander,et al.  Shiga Toxin–Induced Complement-Mediated Hemolysis and Release of Complement-Coated Red Blood Cell–Derived Microvesicles in Hemolytic Uremic Syndrome , 2015, The Journal of Immunology.

[48]  Andrew F. Hill,et al.  Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper , 2015, Journal of extracellular vesicles.

[49]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[50]  Jixin Zhong,et al.  Proangiogenic Compositions of Microvesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells , 2014, PloS one.

[51]  G. La Manna,et al.  Potential advantages of acute kidney injury management by mesenchymal stem cells. , 2014, World journal of stem cells.

[52]  T. Alexy,et al.  TNF-α alters the release and transfer of microparticle-encapsulated miRNAs from endothelial cells. , 2014, Physiological genomics.

[53]  G. Camussi,et al.  Human liver stem cells and derived extracellular vesicles improve recovery in a murine model of acute kidney injury , 2014, Stem Cell Research & Therapy.

[54]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[55]  Taku Murakami,et al.  Development of Glomerulus-, Tubule-, and Collecting Duct-Specific mRNA Assay in Human Urinary Exosomes and Microvesicles , 2014, PloS one.

[56]  L. Gatto,et al.  Human urinary exosomes as innate immune effectors. , 2014, Journal of the American Society of Nephrology : JASN.

[57]  Yuh-Feng Lin,et al.  Exosomal ATF3 RNA Attenuates Pro‐Inflammatory Gene MCP‐1 Transcription in Renal Ischemia‐Reperfusion , 2014, Journal of cellular physiology.

[58]  G. Camussi,et al.  Urinary CD133+ Extracellular Vesicles Are Decreased in Kidney Transplanted Patients with Slow Graft Function and Vascular Damage , 2014, PloS one.

[59]  R. B. Richardson,et al.  A Systematic Review of Preclinical Studies on the Therapeutic Potential of Mesenchymal Stromal Cell-Derived Microvesicles , 2014, Stem Cell Reviews and Reports.

[60]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[61]  Wei Sun,et al.  Urinary extracellular microvesicles: Isolation methods and prospects for urinary proteome , 2014, Proteomics.

[62]  Hua Yang,et al.  Urinary cell mRNA profiles and differential diagnosis of acute kidney graft dysfunction. , 2014, Journal of the American Society of Nephrology : JASN.

[63]  I. Sargent,et al.  Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing , 2014, Journal of thrombosis and haemostasis : JTH.

[64]  Z. Endre,et al.  A Comparison of the Ability of Levels of Urinary Biomarker Proteins and Exosomal mRNA to Predict Outcomes after Renal Transplantation , 2014, PloS one.

[65]  R. Zietse,et al.  Urinary extracellular vesicles and the kidney: biomarkers and beyond. , 2014, American journal of physiology. Renal physiology.

[66]  R. Bertina,et al.  Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections. , 2014, Thrombosis research.

[67]  H. Lindner,et al.  Coordinated binding of Vps4 to ESCRT-III drives membrane neck constriction during MVB vesicle formation , 2014, The Journal of cell biology.

[68]  P. Winyard,et al.  Experimental renal progenitor cells: Repairing and recreating kidneys? , 2014, Pediatric Nephrology.

[69]  Giovanni Camussi,et al.  Cellular phenotype and extracellular vesicles: basic and clinical considerations. , 2014, Stem cells and development.

[70]  P. Quesenberry,et al.  Biodistribution of mesenchymal stem cell-derived extracellular vesicles in a model of acute kidney injury monitored by optical imaging , 2014, International journal of molecular medicine.

[71]  T. Ji,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[72]  Thomas Tuschl,et al.  Urine MicroRNA as Potential Biomarkers of Autosomal Dominant Polycystic Kidney Disease Progression: Description of miRNA Profiles at Baseline , 2014, PloS one.

[73]  K. Ma,et al.  CD2AP mRNA in urinary exosome as biomarker of kidney disease. , 2014, Clinica chimica acta; international journal of clinical chemistry.

[74]  Lynda Chin,et al.  Identification of Double-stranded Genomic DNA Spanning All Chromosomes with Mutated KRAS and p53 DNA in the Serum Exosomes of Patients with Pancreatic Cancer* , 2014, The Journal of Biological Chemistry.

[75]  R. Pink,et al.  Routes and mechanisms of extracellular vesicle uptake , 2014, Journal of extracellular vesicles.

[76]  P. Benaroch,et al.  Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles , 2013, Journal of Cell Science.

[77]  C. Suazo,et al.  Urinary exosomes as a source of kidney dysfunction biomarker in renal transplantation. , 2013, Transplantation proceedings.

[78]  J. Dear,et al.  Quantification of human urinary exosomes by nanoparticle tracking analysis , 2013, The Journal of physiology.

[79]  Doug W. Mahoney,et al.  Subfractionation, characterization and in-depth proteomic analysis of glomerular membrane vesicles in human urine , 2013, Kidney international.

[80]  J. Klawitter,et al.  Cyclosporine induces endothelial cell release of complement-activating microparticles. , 2013, Journal of the American Society of Nephrology : JASN.

[81]  S. Msika,et al.  Microparticle increase in severe obesity: Not related to metabolic syndrome and unchanged after massive weight loss , 2013, Obesity.

[82]  L. Lv,et al.  MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. , 2013, American journal of physiology. Renal physiology.

[83]  D. Motto,et al.  Complement Activation Associated with ADAMTS13 Deficiency in Human and Murine Thrombotic Microangiopathy , 2013, The Journal of Immunology.

[84]  R. Star,et al.  Urinary exosomal Wilms' tumor-1 as a potential biomarker for podocyte injury. , 2013, American journal of physiology. Renal physiology.

[85]  A. Goodall,et al.  Elevated Levels of Procoagulant Plasma Microvesicles in Dialysis Patients , 2013, PloS one.

[86]  J. Malmström,et al.  A Novel Role for Pro-Coagulant Microvesicles in the Early Host Defense against Streptococcus pyogenes , 2013, PLoS pathogens.

[87]  P. Asfar,et al.  Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy , 2013, Intensive Care Medicine.

[88]  J. Dear,et al.  Urinary exosomes: A reservoir for biomarker discovery and potential mediators of intrarenal signalling , 2013, Proteomics.

[89]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[90]  G. Kovacs,et al.  Microparticles and acute renal dysfunction in septic patients. , 2013, Journal of critical care.

[91]  G. Remuzzi,et al.  Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. , 2013, Stem cells and development.

[92]  J. Lötvall,et al.  Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes , 2013, Journal of extracellular vesicles.

[93]  J. Gleadle,et al.  Exosomes and the kidney: Blaming the messenger , 2013, Nephrology.

[94]  E. Letavernier,et al.  Calpastatin controls polymicrobial sepsis by limiting procoagulant microparticle release. , 2012, American journal of respiratory and critical care medicine.

[95]  A. Falus,et al.  Improved Flow Cytometric Assessment Reveals Distinct Microvesicle (Cell-Derived Microparticle) Signatures in Joint Diseases , 2012, PloS one.

[96]  Chunxiang Zhang,et al.  A translational study of urine miRNAs in acute myocardial infarction. , 2012, Journal of molecular and cellular cardiology.

[97]  D. Karolina,et al.  Circulating miRNA profiles in patients with metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[98]  Y. Jan,et al.  TMEM16F Forms a Ca2+-Activated Cation Channel Required for Lipid Scrambling in Platelets during Blood Coagulation , 2012, Cell.

[99]  G. Camussi,et al.  Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. , 2012, Kidney international.

[100]  G. Camussi,et al.  Therapeutic potential of mesenchymal stem cell-derived microvesicles. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[101]  M. Alessi,et al.  Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells , 2012, Journal of cellular and molecular medicine.

[102]  H. Haller,et al.  Microparticle generation and leucocyte death in Shiga toxin-mediated HUS. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[103]  T. Renné,et al.  Platelet‐ and erythrocyte‐derived microparticles trigger thrombin generation via factor XIIa , 2012, Journal of thrombosis and haemostasis : JTH.

[104]  Weihong Zhao,et al.  Bone marrow stem cells‐derived microvesicles protect against renal injury in the mouse remnant kidney model , 2012, Nephrology.

[105]  Yu Luo,et al.  Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes , 2012, Journal of clinical hypertension.

[106]  Julius J Schmidt,et al.  Circulating MicroRNAs Are Not Eliminated by Hemodialysis , 2012, PloS one.

[107]  T. Pisitkun,et al.  Application of systems biology principles to protein biomarker discovery: Urinary exosomal proteome in renal transplantation , 2012, Proteomics. Clinical applications.

[108]  Per Sunnerhagen,et al.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes , 2012, Nucleic acids research.

[109]  G. London,et al.  Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[110]  T. Chavakis,et al.  Developmental Endothelial Locus-1 (Del-1) Mediates Clearance of Platelet Microparticles by the Endothelium , 2012, Circulation.

[111]  H. ten Cate,et al.  Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[112]  L. Truedsson,et al.  Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. , 2012, Arthritis and rheumatism.

[113]  C. Gao,et al.  Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome , 2012, Thrombosis and Haemostasis.

[114]  Jian-Bing Fan,et al.  miR-1289 and “Zipcode”-like Sequence Enrich mRNAs in Microvesicles , 2012, Molecular therapy. Nucleic acids.

[115]  P. Siljander,et al.  Platelet-Derived Microvesicles: Multitalented Participants in Intercellular Communication , 2012, Seminars in Thrombosis & Hemostasis.

[116]  H. Cheong,et al.  Urinary exosomal WT1 in childhood nephrotic syndrome , 2012, Pediatric Nephrology.

[117]  A. Angelillo-Scherrer.  Leukocyte-Derived Microparticles in Vascular Homeostasis , 2012, Circulation research.

[118]  D. Webb,et al.  Identification and proteomic profiling of exosomes in human cerebrospinal fluid , 2012, Journal of Translational Medicine.

[119]  B. W. van Balkom,et al.  Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases , 2011, Kidney International.

[120]  J. Dear,et al.  Exosomal transmission of functional aquaporin 2 in kidney cortical collecting duct cells , 2011, The Journal of physiology.

[121]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[122]  C. Johnsen,et al.  Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.

[123]  Clotilde Théry,et al.  Exosomes: immune properties and potential clinical implementations , 2011, Seminars in Immunopathology.

[124]  A. Simon,et al.  Microparticles, Vascular Function, and Atherothrombosis , 2011, Circulation research.

[125]  M. Saleem,et al.  Monocyte- and Endothelial-Derived Microparticles Induce an Inflammatory Phenotype in Human Podocytes , 2011, Nephron Experimental Nephrology.

[126]  Gang Wang,et al.  Elevated Levels of miR-146a and miR-155 in Kidney Biopsy and Urine from Patients with IgA Nephropathy , 2011, Disease markers.

[127]  S. Sadallah,et al.  Microparticles (Ectosomes) Shed by Stored Human Platelets Downregulate Macrophages and Modify the Development of Dendritic Cells , 2011, The Journal of Immunology.

[128]  D. Hwang,et al.  Proteomic analysis of urinary exosomes from patients of early IgA nephropathy and thin basement membrane nephropathy , 2011, Proteomics.

[129]  A. Edefonti,et al.  Clinical Relevance of Shiga Toxin Concentrations in the Blood of Patients With Hemolytic Uremic Syndrome , 2011, The Pediatric infectious disease journal.

[130]  D. Karpman,et al.  Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. , 2011, Blood.

[131]  N. Mackman,et al.  Microparticles in Hemostasis and Thrombosis , 2011, Circulation research.

[132]  G. Camussi,et al.  Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[133]  D. Eleftheriou,et al.  Thromboembolic disease in systemic vasculitis is associated with enhanced microparticle‐mediated thrombin generation , 2011, Journal of thrombosis and haemostasis : JTH.

[134]  T. McIntyre,et al.  Lipopolysaccharide Signaling without a Nucleus: Kinase Cascades Stimulate Platelet Shedding of Proinflammatory IL-1β–Rich Microparticles , 2011, The Journal of Immunology.

[135]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[136]  S. Pomeroy,et al.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. , 2011, Nature communications.

[137]  J. Freyssinet,et al.  Cellular Mechanisms Underlying the Formation of Circulating Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[138]  S. Nagata,et al.  Calcium-dependent phospholipid scrambling by TMEM16F , 2010, Nature.

[139]  José A López,et al.  Tissue factor, lipid rafts, and microparticles. , 2010, Seminars in thrombosis and hemostasis.

[140]  Kristina M. Little,et al.  The plasma microparticle proteome. , 2010, Seminars in thrombosis and hemostasis.

[141]  G. Camussi,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[142]  C. Weber,et al.  Microparticles: Protagonists of a Novel Communication Network for Intercellular Information Exchange , 2010, Circulation research.

[143]  P. Asfar,et al.  Bench-to-bedside review: Circulating microparticles - a new player in sepsis? , 2010, Critical care.

[144]  J. Klein,et al.  Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. , 2010, Kidney international.

[145]  Shao-Sung Huang,et al.  Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria , 2010, Journal of hypertension.

[146]  Johan Skog,et al.  Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. , 2010, Kidney International.

[147]  P. Williamson,et al.  Phospholipid scramblase: An update , 2010, FEBS letters.

[148]  D. Chan,et al.  Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation , 2010, BMC Cancer.

[149]  N. Klein,et al.  Endothelial injury and repair in systemic vasculitis of the young. , 2010, Arthritis and rheumatism.

[150]  E. Di Angelantonio,et al.  Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. , 2010, Archives of cardiovascular diseases.

[151]  M. Morigi,et al.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.

[152]  D. Connor,et al.  The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib , 2010, Thrombosis and Haemostasis.

[153]  R. Porcher,et al.  Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab , 2010, Haematologica.

[154]  T. D. de Gruijl,et al.  Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.

[155]  S. Lim,et al.  Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and Exosomes* , 2010, Molecular & Cellular Proteomics.

[156]  B. Chauffert,et al.  Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. , 2010, The Journal of clinical investigation.

[157]  Richard W. Farndale,et al.  Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.

[158]  M. Vidal,et al.  Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages. , 2010, Blood.

[159]  C. Ronco,et al.  Protective effect of resin adsorption on septic plasma-induced tubular injury , 2010, Critical care.

[160]  H. Tsai.  Pathophysiology of thrombotic thrombocytopenic purpura , 2010, International journal of hematology.

[161]  James W. Clancy,et al.  ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane Microvesicles , 2009, Current Biology.

[162]  Samuel A Wickline,et al.  Paracrine induction of endothelium by tumor exosomes , 2009, Laboratory Investigation.

[163]  S. Nomura,et al.  Dynamic role of microparticles in type 2 diabetes mellitus. , 2009, Current diabetes reviews.

[164]  X. Mariette,et al.  Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity , 2009, Arthritis research & therapy.

[165]  K. Uchida,et al.  Decreased abundance of urinary exosomal aquaporin-1 in renal ischemia-reperfusion injury. , 2009, American journal of physiology. Renal physiology.

[166]  A. Molinari,et al.  Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells* , 2009, The Journal of Biological Chemistry.

[167]  D. Karpman,et al.  Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic Syndrome , 2009, PloS one.

[168]  I. Giles,et al.  Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome? , 2009, Lupus.

[169]  A. Christensson,et al.  Neutrophil-Derived Proteinase 3 Induces Kallikrein-Independent Release of a Novel Vasoactive Kinin12 , 2009, The Journal of Immunology.

[170]  F. Meziani.  Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats* , 2009, Critical care medicine.

[171]  Z. Yang,et al.  Elevated circulating endothelial microparticles and brachial–ankle pulse wave velocity in well-controlled hypertensive patients , 2009, Journal of Human Hypertension.

[172]  J. Bonventre.  Microvesicles from mesenchymal stromal cells protect against acute kidney injury. , 2009, Journal of the American Society of Nephrology : JASN.

[173]  Alessandro Busca,et al.  Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. , 2009, Journal of the American Society of Nephrology : JASN.

[174]  X. Breakefield,et al.  Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer , 2009, British Journal of Cancer.

[175]  S. Nomura,et al.  Effects of eicosapentaenoic acid on endothelial cell-derived microparticles, angiopoietins and adiponectin in patients with type 2 diabetes. , 2009, Journal of atherosclerosis and thrombosis.

[176]  R. Kerbel,et al.  Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR , 2009, Proceedings of the National Academy of Sciences.

[177]  K. Fukudome,et al.  Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects , 2009, Haematologica.

[178]  L. Arnaud,et al.  Kidney Transplantation Decreases the Level and Procoagulant Activity of Circulating Microparticles , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[179]  D. Karpman,et al.  Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura , 2009, Pediatric Nephrology.

[180]  Willem Stoorvogel,et al.  Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. , 2009, Blood.

[181]  N. LaRusso,et al.  Characterization of PKD protein-positive exosome-like vesicles. , 2009, Journal of the American Society of Nephrology : JASN.

[182]  J. Pober,et al.  Cytomegalovirus-Infected Human Endothelial Cells Can Stimulate Allogeneic CD4+ Memory T Cells by Releasing Antigenic Exosomes1 , 2009, The Journal of Immunology.

[183]  Trairak Pisitkun,et al.  Large-scale proteomics and phosphoproteomics of urinary exosomes. , 2009, Journal of the American Society of Nephrology : JASN.

[184]  Jacopo Meldolesi,et al.  Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.

[185]  T. Iwasaka,et al.  The effects of pitavastatin, eicosapentaenoic acid and combined therapy on platelet-derived microparticles and adiponectin in hyperlipidemic, diabetic patients , 2009, Platelets.

[186]  J. Hudson,et al.  Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. , 2008, Biochimica et biophysica acta.

[187]  R. Andriantsitohaina,et al.  Circulating microparticles from patients with septic shock exert protective role in vascular function. , 2008, American journal of respiratory and critical care medicine.

[188]  M. Haubitz,et al.  Diagnostic role of endothelial microparticles in vasculitis. , 2008, Rheumatology.

[189]  G. Leftheriotis,et al.  Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. , 2008, The American journal of pathology.

[190]  D. Terrian,et al.  Senescence-associated exosome release from human prostate cancer cells. , 2008, Cancer research.

[191]  C. Ballantyne,et al.  Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles. , 2008, Blood.

[192]  G. Illei,et al.  Urinary exosomal transcription factors, a new class of biomarkers for renal disease. , 2008, Kidney international.

[193]  T. Nakayama,et al.  Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome , 2008, Thrombosis and Haemostasis.

[194]  P. Giri,et al.  Exosomes Derived from M. Bovis BCG Infected Macrophages Activate Antigen-Specific CD4+ and CD8+ T Cells In Vitro and In Vivo , 2008, PloS one.

[195]  V. Afshar-Kharghan.  Unleashed platelets in aHUS. , 2008, Blood.

[196]  P. Zipfel,et al.  Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. , 2008, Blood.

[197]  T. Ratliff,et al.  Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. , 2008, Blood.

[198]  A. Tedgui,et al.  Role of microparticles in atherothrombosis , 2008, Journal of internal medicine.

[199]  V. Ranieri,et al.  Circulating plasma factors induce tubular and glomerular alterations in septic burns patients , 2008, Critical care.

[200]  Simon C Watkins,et al.  Exosomes As a Short-Range Mechanism to Spread Alloantigen between Dendritic Cells during T Cell Allorecognition1 , 2008, The Journal of Immunology.

[201]  W. Yin,et al.  Expression of complement components and inhibitors on platelet microparticles , 2008, Platelets.

[202]  P. Altevogt,et al.  CD24 is a marker of exosomes secreted into urine and amniotic fluid. , 2007, Kidney international.

[203]  H. Cheong,et al.  Reduced urinary excretion of thiazide-sensitive Na-Cl cotransporter in Gitelman syndrome: preliminary data. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[204]  J. Xiang,et al.  Nonspecific CD4+ T cells with uptake of antigen‐specific dendritic cell‐released exosomes stimulate antigen‐specific CD8+ CTL responses and long‐term T cell memory , 2007, Journal of leukocyte biology.

[205]  M. Wellner,et al.  β2-Integrins and Acquired Glycoprotein IIb/IIIa (GPIIb/IIIa) Receptors Cooperate in NF-κB Activation of Human Neutrophils*♦ , 2007, Journal of Biological Chemistry.

[206]  P. Quesenberry,et al.  Alteration of Marrow Cell Gene Expression, Protein Production, and Engraftment into Lung by Lung‐Derived Microvesicles: A Novel Mechanism for Phenotype Modulation , 2007, Stem cells.

[207]  Riitta Lahesmaa,et al.  Exosomes with Immune Modulatory Features Are Present in Human Breast Milk1 , 2007, The Journal of Immunology.

[208]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[209]  F. Di Virgilio,et al.  Stimulation of P2 receptors causes release of IL-1beta-loaded microvesicles from human dendritic cells. , 2007, Blood.

[210]  G. London,et al.  In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal Disease , 2007, Hypertension.

[211]  Mikhail A Panteleev,et al.  Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets , 2007, Thrombosis and Haemostasis.

[212]  J. Freyssinet,et al.  Procoagulant Microparticles: Disrupting the Vascular Homeostasis Equation? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[213]  R. Star,et al.  Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. , 2006, Kidney international.

[214]  B. Loriod,et al.  Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. , 2006, Blood.

[215]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[216]  D. Giugliano,et al.  Pioglitazone reduces endothelial microparticles in the metabolic syndrome. , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[217]  Hong Wang,et al.  Rapid clearance of procoagulant platelet‐derived microparticles from the circulation of rabbits , 2006, Journal of thrombosis and haemostasis : JTH.

[218]  L. Horstman,et al.  Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. , 2006, The American journal of cardiology.

[219]  Ping Wang,et al.  DENDRITIC CELL-DERIVED EXOSOMES CONTAINING MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR-FACTOR VIII ATTENUATE PROINFLAMMATORY RESPONSES IN SEPSIS , 2006, Shock.

[220]  P Lesavre,et al.  Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. , 2006, Kidney international.

[221]  V. Faure,et al.  Elevation of circulating endothelial microparticles in patients with chronic renal failure , 2006, Journal of thrombosis and haemostasis : JTH.

[222]  Darwin J. Prockop,et al.  Mitochondrial transfer between cells can rescue aerobic respiration , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[223]  D. Pisetsky,et al.  Microparticles as mediators of cellular cross-talk in inflammatory disease , 2006, Autoimmunity.

[224]  R. Nieuwland,et al.  The phospholipid composition and cholesterol content of platelet‐derived microparticles: a comparison with platelet membrane fractions , 2005, Journal of thrombosis and haemostasis : JTH.

[225]  Chantal M Boulanger,et al.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[226]  R. Schein,et al.  Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis , 2005, Critical care medicine.

[227]  José A López,et al.  Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. , 2005, Blood.

[228]  Roeland M. H. Merks,et al.  Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. , 2005, American journal of physiology. Heart and circulatory physiology.

[229]  A. Zernecke,et al.  Platelet Microparticles: A Transcellular Delivery System for RANTES Promoting Monocyte Recruitment on Endothelium , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[230]  T. Möller,et al.  Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.

[231]  K. Ekdahl,et al.  Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. , 2005 .

[232]  L. Horstman,et al.  Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. , 2005, Journal of the American College of Cardiology.

[233]  Anna Janowska-Wieczorek,et al.  Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer , 2005, International journal of cancer.

[234]  K. Fukudome,et al.  Activated protein C induces the release of microparticle-associated endothelial protein C receptor. , 2005, Blood.

[235]  A. Schmaier,et al.  D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis , 2004, Thrombosis and Haemostasis.

[236]  A. Brill,et al.  Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. , 2004, Cardiovascular research.

[237]  J. Schifferli,et al.  Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. , 2004, Blood.

[238]  D. Fishman,et al.  Proinvasive Properties of Ovarian Cancer Ascites-Derived Membrane Vesicles , 2004, Cancer Research.

[239]  Rong-Fong Shen,et al.  Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[240]  N. Takahashi,et al.  Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. , 2004, Atherosclerosis.

[241]  Sébastien Roy,et al.  Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. , 2004, The Biochemical journal.

[242]  D. Mant,et al.  Endothelial and platelet microparticles in vasculitis of the young. , 2004, Arthritis and rheumatism.

[243]  H. K. Kim,et al.  Platelet microparticles induce angiogenesis in vitro , 2004, British journal of haematology.

[244]  F. Dignat-George,et al.  Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome , 2004, Thrombosis and Haemostasis.

[245]  G. Raposo,et al.  Lipid raft-associated protein sorting in exosomes. , 2003, Blood.

[246]  L. Horstman,et al.  Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation , 2003, British journal of haematology.

[247]  C. Usal,et al.  Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection1 , 2003, Transplantation.

[248]  P. Houillier,et al.  Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[249]  A. Booth,et al.  The Trojan exosome hypothesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[250]  J. Chou,et al.  Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.

[251]  J. Thistlethwaite,et al.  Platelets and capillary injury in acute humoral rejection of renal allografts. , 2003, Human pathology.

[252]  C. Hess,et al.  Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. , 2003, Experimental cell research.

[253]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.

[254]  D. Daleke.  Regulation of transbilayer plasma membrane phospholipid asymmetry Published, JLR Papers in Press, December 16, 2002. DOI 10.1194/jlr.R200019-JLR200 , 2003, Journal of Lipid Research.

[255]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[256]  M. Ratajczak,et al.  Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV , 2003, AIDS.

[257]  R. Nieuwland,et al.  Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus , 2002, Circulation.

[258]  K. Tsuchiya,et al.  Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. , 2002, Kidney international.

[259]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[260]  L. Truedsson,et al.  Contact-system activation in children with vasculitis , 2002, The Lancet.

[261]  S. Nomura,et al.  Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus , 2002, Journal of Human Hypertension.

[262]  L. Zitvogel,et al.  Malignant effusions and immunogenic tumour-derived exosomes , 2002, The Lancet.

[263]  M. A. van de Laar,et al.  Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[264]  F. Dignat-George,et al.  Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. , 2002, Blood.

[265]  D. Praticò,et al.  Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. , 2002, Experimental hematology.

[266]  T. Iwasaka,et al.  Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus , 2002, Diabetologia.

[267]  M. Ratajczak,et al.  Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. , 2001, Blood.

[268]  T. Foroud,et al.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura , 2001, Nature.

[269]  K. Nilsson,et al.  Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome. , 2001, Blood.

[270]  C. Hack,et al.  Microparticles from Patients with Multiple Organ Dysfunction Syndrome and Sepsis Support Coagulation through Multiple Mechanisms , 2001, Thrombosis and Haemostasis.

[271]  C. Hack,et al.  Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.

[272]  A. Namane,et al.  Mast Cell-Dependent B and T Lymphocyte Activation Is Mediated by the Secretion of Immunologically Active Exosomes1 , 2001, The Journal of Immunology.

[273]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[274]  R. Westendorp,et al.  Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. , 2000, Blood.

[275]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[276]  M. Mesri,et al.  Endothelial cell activation by leukocyte microparticles. , 1998, Journal of immunology.

[277]  G. FitzGerald,et al.  Modulation of monocyte-endothelial cell interactions by platelet microparticles. , 1998, The Journal of clinical investigation.

[278]  M. Vidal,et al.  Decay-accelerating factor (CD55) and membrane inhibitor of reactive lysis (CD59) are released within exosomes during In vitro maturation of reticulocytes. , 1998, Blood.

[279]  G. FitzGerald,et al.  Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. , 1997, The Journal of clinical investigation.

[280]  T. Mori,et al.  The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane. , 1993, Thrombosis research.

[281]  J. Kelton,et al.  Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. , 1992, Blood.

[282]  V. Nussenzweig,et al.  Membrane vesiculation protects erythrocytes from destruction by complement. , 1991, Journal of immunology.

[283]  B. Furie,et al.  Platelet-derived microparticles express high affinity receptors for factor VIII. , 1991, The Journal of biological chemistry.

[284]  M. C. Han,et al.  Paroxysmal Nocturnal Hemoglobinuria , 1991 .

[285]  J. Griffin,et al.  Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. , 1991, Blood.

[286]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[287]  J. George,et al.  Isolation of human platelet membrane microparticles from plasma and serum. , 1982, Blood.

[288]  M. Mack.  Leukocyte-derived microvesicles dock on glomerular endothelial cells: stardust in the kidney. , 2017, Kidney international.

[289]  M. Mörgelin,et al.  Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis. , 2017, Kidney international.

[290]  T. Le,et al.  Extracellular Vesicles in Renal Diseases: More than Novel Biomarkers? , 2016, Journal of the American Society of Nephrology : JASN.

[291]  Á. Kittel,et al.  PHAGOCYTES , GRANULOCYTES , AND MYELOPOIESIS Antibacterial effect of microvesicles released from human neutrophilic granulocytes * , 2013 .

[292]  Shinobu Ueda,et al.  Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[293]  N. Klein,et al.  Anti-neutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles. , 2012, Journal of the American Society of Nephrology : JASN.

[294]  G. Camussi,et al.  Isolation and characterization of resident mesenchymal stem cells in human glomeruli. , 2012, Methods in molecular biology.

[295]  G. Camussi,et al.  Role of microvesicles in acute kidney injury. , 2011, Contributions to nephrology.

[296]  G. Illei,et al.  Exosomes from human saliva as a source of microRNA biomarkers. , 2010, Oral diseases.

[297]  Michele Guescini,et al.  Astrocytes and Glioblastoma cells release exosomes carrying mtDNA , 2009, Journal of Neural Transmission.

[298]  R. Nieuwland,et al.  Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. , 2008, Thrombosis research.

[299]  A. Simon,et al.  Endothelial microparticles in diseases , 2008, Cell and Tissue Research.

[300]  G. Parmiani,et al.  Tumour-released exosomes and their implications in cancer immunity , 2008, Cell Death and Differentiation.

[301]  Link,et al.  UvA-DARE ( Digital Academic Repository ) Endothelial cell-derived microparticles , 2007 .

[302]  H. Horigome,et al.  Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. , 2007, Thrombosis research.

[303]  A. Tedgui,et al.  Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. , 2006, Hypertension.

[304]  E. Bouhassira,et al.  Congenital Factor V Deficiency Low Plasma Levels of Tissue Factor Pathway Inhibitor in Patients With , 2006 .

[305]  G. Ronquist,et al.  Promotive effect on human sperm progressive motility by prostasomes , 2004, Urological Research.